日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints

皮肤来源的髓系前体细胞和关节驻留成纤维细胞将银屑病从皮肤扩散到关节。

Raimondo, Maria G; Mohammadian, Hashem; Angeli, Mario R; Alivernini, Stefano; Fedorchenko, Vladyslav; Huang, Kaiyue; Demmler, Richard; Rhein, Peter; Xu, Cong; Li, Yi-Nan; Micheroli, Raphael; Winter, Zoltán; Rigau, Aleix Rius; Anchang, Charles G; Soare, Alina; Luber, Markus; Labinsky, Hannah; Chang, Jiyang; Günther, Claudia; Fearon, Ursula; Veale, Douglas J; Ciccia, Francesco; Rech, Jürgen; Sticherling, Michael; Bäuerle, Tobias; Distler, Jörg H W; Kurowska-Stolarska, Mariola S; Mack, Matthias; Ekici, Arif B; Croft, Adam P; Distler, Oliver; Maric, Hans M; Ospelt, Caroline; Cañete, Juan D; D'Agostino, Maria A; Schett, Georg; Rauber, Simon; Ramming, Andreas

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414

关于在未接受过生物制剂DMARD治疗的活动性银屑病关节炎患者中应用Bimekizumab治疗的更正:来自III期随机、安慰剂对照、活性参考BE OPTIMAL研究的52周疗效和安全性结果 Ann Rheum Dis. 2023;82:1404-1414

Ritchlin, Christopher T; Coates, Laura C; McInnes, Iain B; Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Asahina, Akihiko; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Landewé, Robert B M

Machine learning-guided composite ionic liquid-based system for dual-drug delivery targeting redox homeostasis and STAT3-PI3K axis in psoriasis therapy

基于机器学习的复合离子液体双药递送系统,靶向银屑病治疗中的氧化还原稳态和STAT3-PI3K轴。

Zeng, Meng; Deng, Ping; Yang, Qian; Hu, Jie; Li, Jixiang; Tang, Qi; Pu, Xiaoyan; Zhang, Liangke

Reshaping psoriasis topical therapy: Continuous hydrogenation orchestrates 'redox-metabolic homeostasis' for efficient remission and relapse intervention

重塑银屑病局部治疗:持续氢化作用调控“氧化还原代谢稳态”,实现有效缓解和复发干预

Lin, Lanmei; Guan, Qingqing; Ding, Zhiguang; Zou, Jianxin; Dong, Canbin; Zhu, Xinyi; Fan, Weijian; Li, Han; Xu, Jinhua; Tan, Jinyun; Ding, Wenjiang; Pei, Jia; Du, Juan

Targeting KAT8 alleviates self-RNA-driven skin inflammation by modulating histone H4 lysine 16 acetylation in psoriasis.

靶向 KAT8 可通过调节组蛋白 H4 赖氨酸 16 乙酰化来缓解银屑病中由自身 RNA 驱动的皮肤炎症。

Xiang Yan, Jiang Yuyu, Wang Zeting, Wang Xiaohui, Ma Lijie, Ding Yingying, Rui Bing, Zhao Chunyan, Li Xiangyu, Xu Mingyuan, Zhang Yunkai, Zhan Zhenzhen, Liu Xingguang

Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis

氧气增强型双段微针贴片可增强药物渗透,改善银屑病的光动力和抗炎治疗效果

Yuan, Yaqi; Jiang, Peng; Xiao, Chuan; Lei, Jiapeng; Cheng, Bo; Hu, Hankun; Li, Wei

Advancing psoriasis therapy through oxygen-boosted dual-section microneedle technology

利用氧气增强型双段微针技术推进银屑病治疗

Albakr, Lamyaa; Kang, Lifeng

Population-Based Multi-Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease

基于人群的多组学和队列研究:识别银屑病的预测性生物标志物和治疗靶点

Wu, Tianxing; Luo, Jialiang; Qiu, Haoyuan; Shao, Weijie; Lu, Yueyang; Luo, Meixuan; Lin, Zhaofeng; Zhang, Yan; Zhang, Libo; Wang, Hong; Zhou, Jia; Ruan, Guangfeng; Cao, Peihua; Zuo, Daming

Self-Assembled Dictamni Cortex Nanoparticles Ameliorate Psoriasis by Epigenetic Modulation of HSP90AB1 and Suppression of the Inflammatory Response

自组装的白鲜皮层纳米颗粒通过表观遗传调控HSP90AB1和抑制炎症反应来改善银屑病

Zhang, Zhengyi; Du, Wenqian; Zhang, Xiaojiang; Cui, Hongbo; Cheng, Baochen; Han, Xiao; He, Ke; Yin, Tingyi; Liu, Xinyi; Xian, Ningyi; Wang, Ziyang; Liu, Meng; Han, Dan; Liu, Jiankang; Zheng, Yan; Wang, Ya

Systemic CSF1R Targeting Depletes Pathogenic MPS Bubs and Ameliorates Psoriasis via PPARα-mediated Resolution.

系统性 CSF1R 靶向治疗可清除致病性 MPS 芽体,并通过 PPARα 介导的消退作用改善银屑病。

Lin Zhen-Jia, Li Ying, Yu Yangyinhui, Fang Mei-Jia, Xiong Ying, Xu Rui, Wang Zhuo, Zhang Jun, Xu Ya-Nan, Wan Jun-Ya, Ji Xiang, Zheng Yu-Fan, Zhang Kai-Lang, Wei Ming, Zou Jun-Tao, Jia Li-Xuan, Zhang Hui, Li Chang-Lin, Zhou Li-Jun, Tan Zhi